1
|
Moukhtari SHE, Muñoz-Juan A, Del Campo-Montoya R, Laromaine A, Blanco-Prieto MJ. Biosafety evaluation of etoposide lipid nanomedicines in C. elegans. Drug Deliv Transl Res 2024; 14:2158-2169. [PMID: 38363484 DOI: 10.1007/s13346-023-01466-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/24/2023] [Indexed: 02/17/2024]
Abstract
Neuroblastoma is a pediatric tumor that originates during embryonic development and progresses into aggressive tumors, primarily affecting children under two years old. Many patients are diagnosed as high-risk and undergo chemotherapy, often leading to short- and long-term toxicities. Nanomedicine offers a promising solution to enhance drug efficacy and improve physical properties. In this study, lipid-based nanomedicines were developed with an average size of 140 nm, achieving a high encapsulation efficiency of over 90% for the anticancer drug etoposide. Then, cytotoxicity and apoptosis-inducing effects of these etoposide nanomedicines were assessed in vitro using human cell lines, both cancerous and non-cancerous. The results demonstrated that etoposide nanomedicines exhibited high toxicity and selectively induced apoptosis only in cancerous cells.Next, the biosafety of these nanomedicines in C. elegans, a model organism, was evaluated by measuring survival, body size, and the effect on dividing cells. The findings showed that the nanomedicines had a safer profile than the free etoposide in this model. Notably, nanomedicines exerted etoposide's antiproliferative effect only in highly proliferative germline cells. Therefore, the developed nanomedicines hold promise as safe drug delivery systems for etoposide, potentially leading to an improved therapeutic index for neuroblastoma treatment.
Collapse
Affiliation(s)
- Souhaila H El Moukhtari
- Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008, Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008, Pamplona, Spain
| | - Amanda Muñoz-Juan
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193, Bellaterra, Spain
| | - Rubén Del Campo-Montoya
- Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008, Pamplona, Spain
- Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008, Pamplona, Spain
| | - Anna Laromaine
- Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus UAB, 08193, Bellaterra, Spain.
| | - María J Blanco-Prieto
- Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, Universidad de Navarra, C/Irunlarrea 1, 31008, Pamplona, Spain.
- Instituto de Investigación Sanitaria de Navarra, IdiSNA, C/Irunlarrea 3, 31008, Pamplona, Spain.
| |
Collapse
|
2
|
Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An ultra-high-performance chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023; 227:115290. [PMID: 36812796 DOI: 10.1016/j.jpba.2023.115290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Revised: 02/11/2023] [Accepted: 02/11/2023] [Indexed: 02/17/2023]
Abstract
Gemcitabine is an analogue of cytidine arabinoside, used alone or in combination chemotherapy to treat various type of cancer. The dose-banding of gemcitabine provides the opportunity to anticipate the preparation of this anticancer drug on condition of carrying out stability studies. The aim of this study is to develop and validate a stability-indicating ultra-high-performance Liquid Chromatography (UHPLC) method for measuring the concentration of gemcitabine and to evaluate its stability at standardised rounded doses in polyolefin bags. The UHPLC with photodiode array (PDA) detector method was developed and validated (linearity, precision, accuracy, limits of detection and quantification, robustness and degradation test). Thirty polyolefin bags of gemcitabine (1600 mg/292 ml (n = 10), 1800 mg/297 ml (n = 10) and 2000 mg/303 ml (n = 10)) were prepared under aseptic conditions and stored at 5 ± 3 °C and 23 ± 2 °C for 49 days. Physical stability tests were periodically performed: visual and microscopic inspection and optical densities. The chemical stability was evaluated through pH monitoring and chromatographic assays. The results confirm the stability of Gemcitabine at selected standardised rounded doses of 1600 mg, 1800 mg and 2000 mg in NaCl 0.9% polyolefin bags for at least 49 days at 5 ± 3 °C and 23 ± 2 °C, allowing in-advance preparation.
Collapse
Affiliation(s)
- Mélanie Closset
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium.
| | - Marie-Lise Colsoul
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Nicolas Goderniaux
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Benoît Bihin
- Scientific Support Unit, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Jacques Jamart
- Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Sabrina Onorati
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Laura Soumoy
- Department of Pharmacy, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Jean-Daniel Hecq
- Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Pascal Odou
- Université de Lille, CHU Lille, ULR7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
| | - Laurence Galanti
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| |
Collapse
|
3
|
van der Heijden L, Gebretensae A, Thijssen B, van Andel L, Nijstad A, Wang Y, Rosing H, Huitema A, Beijnen J. A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-O-deacetylvinorelbine in human plasma using LC-MS/MS. J Pharm Biomed Anal 2022; 215:114772. [DOI: 10.1016/j.jpba.2022.114772] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Revised: 04/12/2022] [Accepted: 04/13/2022] [Indexed: 11/27/2022]
|
4
|
Özkan A, Atar N, Yola ML. Enhanced surface plasmon resonance (SPR) signals based on immobilization of core-shell nanoparticles incorporated boron nitride nanosheets: Development of molecularly imprinted SPR nanosensor for anticancer drug, etoposide. Biosens Bioelectron 2019; 130:293-298. [DOI: 10.1016/j.bios.2019.01.053] [Citation(s) in RCA: 60] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2018] [Revised: 01/20/2019] [Accepted: 01/22/2019] [Indexed: 01/06/2023]
|
5
|
Kurbanoglu S, Bakirhan NK, Gumustas M, Ozkan SA. Modern Assay Techniques for Cancer Drugs: Electroanalytical and Liquid Chromatography Methods. Crit Rev Anal Chem 2019; 49:306-323. [PMID: 30595027 DOI: 10.1080/10408347.2018.1527206] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
In the past decades, patients who have chemotherapy treatment have considerably increased number. At this point, the development of rapid precise, and reliable methods are very important to analyze cancer drugs from their dosage forms, animals or human biological samples. Among all the analytical methods, electrochemical methods hold an important position with their unique properties such as specificity in the biological recognition process, fast response, and their reliability and do not need a pretreatment process. Chromatographic methods are also used in a wide range of analytical applications for the analyses of anticancer drugs. The power of chromatography comes from its ability to separate a mixture of analytes and determination of their concentrations. Chromatographic techniques can mainly be divided into gas, liquid, and supercritical fluid chromatography. In the frame of this information, this review is aimed to provide basic principles of electroanalytical and high-performance liquid chromatography methods for the analysis of cancer drugs. In addition, some selected applications for electrochemistry-related techniques and high-performance liquid chromatography, for the determination of anti-cancer pharmaceuticals published in the last five years are also discussed.
Collapse
Affiliation(s)
- Sevinc Kurbanoglu
- a Faculty of Pharmacy, Department of Analytical Chemistry , Ankara University , Ankara , Turkey
| | - Nurgul K Bakirhan
- b Faculty of Science and Art, Department of Chemistry , Hitit University , Çorum , Turkey
| | - Mehmet Gumustas
- c Department of Forensic Toxicology , Ankara University Institute of Forensic Sciences , Ankara , Turkey
| | - Sibel A Ozkan
- a Faculty of Pharmacy, Department of Analytical Chemistry , Ankara University , Ankara , Turkey
| |
Collapse
|
6
|
Xu RA, Lin Q, Qiu X, Chen J, Shao Y, Hu G, Lin G. UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma. J Pharm Biomed Anal 2018; 166:6-12. [PMID: 30594035 DOI: 10.1016/j.jpba.2018.12.036] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Revised: 12/20/2018] [Accepted: 12/21/2018] [Indexed: 11/26/2022]
Abstract
In the present study, a simple ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method used to measure the plasma concentrations of imatinib, voriconazole and their metabolites (N-desmethyl imatinib and N-oxide voriconazole) in rats simultaneously making use of diazepam as the internal standard (IS) had been developed and validated. A simple protein precipitation by acetonitrile was employed for the sample preparation, then the analytes (imatinib, voriconazole and their metabolites) were eluted on an Acquity UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 μm) using the mobile phase that made up by acetonitrile (A) and 0.1% formic acid in water (B). In positive ion mode, four analytes and IS were monitored by multiple reaction monitoring (MRM) as the following mass transition pairs: m/z 494.3→394.2 for imatinib, m/z 480.3→394.2 for N-desmethyl imatinib, m/z 350.1→281.1 for voriconazole, m/z 366.1→224.1 for N-oxide voriconazole, and m/z 285.0→154.0 for IS. This method exhibited a good linearity for each analyte. Inter-day and intra-day precision were determined with values of 0.3-14.8% and 2.6-14.8%, respectively; the accuracy values were from -12.5% to 10.2%. Finally, data of matrix effect, extraction recovery, and stability were all conformed to the bioanalytical method validation of acceptance criteria of FDA recommendations. This method is an efficient tool for simultaneous determination of the four analytes and has been successfully applied for pharmacokinetic study in rats.
Collapse
Affiliation(s)
- Ren-Ai Xu
- The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, PR China
| | - Qianmeng Lin
- The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, PR China; School of Pharmaceutical Sciences, Wenzhou Medical University, 325000, Wenzhou, PR China
| | - Xiangjun Qiu
- Medical College of Henan University of Science and Technology, 471003, Luoyang, PR China
| | - Jingjing Chen
- The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, PR China
| | - Yuanyuan Shao
- The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, PR China
| | - Guoxin Hu
- The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, PR China; School of Pharmaceutical Sciences, Wenzhou Medical University, 325000, Wenzhou, PR China.
| | - Guanyang Lin
- The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, PR China.
| |
Collapse
|
7
|
Gao S, Tao Z, Zhou J, Wang Z, Yun Y, Li M, Zhang F, Chen W, Miao Y. One-Step Solid Extraction for Simultaneous Determination of Eleven Commonly Used Anticancer Drugs and One Active Metabolite in Human Plasma by HPLC-MS/MS. JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY 2018; 2018:7967694. [PMID: 30046507 PMCID: PMC6036832 DOI: 10.1155/2018/7967694] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Accepted: 05/07/2018] [Indexed: 06/08/2023]
Abstract
Therapeutic drug monitoring for anticancer drugs could timely reflect in vivo drug exposure, and it was a powerful tool for adjusting and maintaining drug concentration into a reasonable range, so that an enhanced efficacy and declined adverse reactions could be achieved. A liquid chromatography-tandem mass spectrometry method had been developed and fully validated for simultaneous determination of paclitaxel, docetaxel, vinblastine, vinorelbine, pemetrexed, carboplatin, etoposide, cyclophosphamide, ifosfamide, gemcitabine, irinotecan, and SN-38 (an active metabolite of irinotecan) in human plasma from cancer patients after intravenous drip of chemotherapy drugs. One-step solid-phase extraction was successfully applied using an Ostro sample preparation 96-well plate for plasma samples pretreated with acetonitrile containing 0.1% formic acid. Chromatographic separation was achieved on an Atlantis T3-C18 column (2.1 × 100 mm, 3.0 μm) with gradient elution using a mobile phase consisting of acetonitrile and 10 mM ammonium acetate plus 0.1% formic acid in water, and the flow rate was 0.25 mL/min. The Agilent G6410A triple quadrupole liquid chromatography-mass spectrometry system was operated under the multiple reaction monitoring mode with an electrospray ionization in the positive mode. Linear range was 25.0-2500.0 ng for paclitaxel, 10.0-1000.0 ng for docetaxel and SN-38, 100.0-10000.0 ng for vinorelbine and pemetrexed, 10.0-10000.0 ng for vinblastine and irinotecan, 1.0-1000.0 ng for cyclophosphamide and ifosfamide, 50.0-5000.0 ng for carboplatin, etoposide, and gemcitabine. Linearity coefficients of correlation were >0.99 for all analytes. The intraday and interday accuracy and precision of the method were within ±15.0% and less than 15%. The mean recovery and matrix effect as well as stability of all the analytes ranged from 56.2% to 98.9% and 85.2% to 101.3% as well as within ±15.0%. This robust and efficient method was successfully applied to implement therapeutic drug monitoring for cancer patients in clinical application.
Collapse
Affiliation(s)
- Shouhong Gao
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Zhengbo Tao
- Department of Orthopaedics, First Affiliated Hospital, China Medical University, 155 Nan Jing Bei Street, Shenyang, Liaoning 110001, China
| | - Jingya Zhou
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Zhipeng Wang
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Yunlei Yun
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Mingming Li
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Feng Zhang
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Wansheng Chen
- Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
| | - Yejun Miao
- Department of Psychiatry, Ankang Hospital, Ningbo, Zhejiang 315000, China
| |
Collapse
|
8
|
Corona G, Gusella M, Gaspardo A, Miolo G, Bertolaso L, Pezzolo E, Pasini F, Steffan A, Caruso D. Rapid LC-MS/MS method for quantification of vinorelbine and 4-O-deacetylvinorelbine in human whole blood suitable to monitoring oral metronomic anticancer therapy. Biomed Chromatogr 2018; 32:e4282. [PMID: 29749011 DOI: 10.1002/bmc.4282] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2018] [Revised: 04/23/2018] [Accepted: 04/27/2018] [Indexed: 12/27/2022]
Abstract
A rapid and sensitive LC-MS/MS method for therapeutic drug monitoring oral vinorelbine (VRL) metronomic anticancer chemotherapy has been developed and validated. Analysis of VRL and its main active metabolite 4-O-deacetylvinorelbine (M1) was performed in whole blood matrix. Both analytes were extracted by protein precipitation and separated on an Onyx monolith C18 , 50 × 2 mm column then quantified by positive electrospray ionization and multiple reaction monitoring mode. The LLOQ was 0.05 ng/mL for both VRL and M1. Linearity was up to 25ng/mL with R2 ≥ 0.994. The intra- and inter-assay precisions were ≤ 11.6 and ≤ 10.4% while the ranges of accuracy were [-8.7%; 10.3%] and [-10.0; 7.4%] for VRL and M1, respectively. The clinical suitability of the method has been proved by the determination of the CTrough blood concentrations of VRL and M1 in 64 nonsmall cell lung cancer elderly patients. The analytical performance of the assay was suitable for pharmacokinetic monitoring of VRL and M1, allowing the personalization of the VRL metronomic treatments.
Collapse
Affiliation(s)
- Giuseppe Corona
- Immunopathology and Cancer Biomarkers Unit, Translational Research Department, IRCCS National Cancer Institute, Aviano, Italy
| | - Milena Gusella
- Oncology Department, Santa Maria della Misericordia Hospital, Rovigo, Italy
| | - Anna Gaspardo
- Pharmacological and Biomolecular Science Department, University of Milan Milan, Italy
| | - Gianmaria Miolo
- Medical and Preventive Oncology Unit, IRCCS National Cancer Institute, Aviano, Italy
| | - Laura Bertolaso
- Oncology Department, Santa Maria della Misericordia Hospital, Rovigo, Italy
| | - Elisa Pezzolo
- Oncology Department, Santa Maria della Misericordia Hospital, Rovigo, Italy
| | - Felice Pasini
- Medical Oncology Unit, Piero Pederzoli Hospital, Peschiera del Garda, Italy
| | - Agostino Steffan
- Immunopathology and Cancer Biomarkers Unit, Translational Research Department, IRCCS National Cancer Institute, Aviano, Italy
| | - Donatella Caruso
- Pharmacological and Biomolecular Science Department, University of Milan Milan, Italy
| |
Collapse
|
9
|
Li D, Zhao G, Ai W, Li G, Si L, Huang J, Chen Y, Wu S. Simultaneous LC-MS/MS bioanalysis of etoposide and paclitaxel in mouse tissues and plasma after oral administration of self-microemulsifying drug-delivery systems. Biomed Chromatogr 2018; 32:e4192. [PMID: 29349799 DOI: 10.1002/bmc.4192] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2017] [Revised: 12/13/2017] [Accepted: 01/09/2018] [Indexed: 12/27/2022]
Affiliation(s)
- Dan Li
- Department of Pharmacy; Shenzhen University Genneral Hospital; Shenzhen Guangdong People' Republic of China
- Department of Pharmaceutics, School of Pharmacy, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
| | - Gang Zhao
- Department of Pharmaceutics, School of Pharmacy, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
- Institute of Pharmaceutical Research; Jianmin Pharmaceutical Group; Wuhan People' Republic of China
| | - Weipeng Ai
- Department of Pharmacy; Shenzhen University Genneral Hospital; Shenzhen Guangdong People' Republic of China
| | - Gao Li
- Department of Pharmaceutics, School of Pharmacy, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
| | - Luqin Si
- Department of Pharmaceutics, School of Pharmacy, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
| | - Jiangeng Huang
- Department of Pharmaceutics, School of Pharmacy, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
| | - Yunzhou Chen
- Department of Pharmacy, Tongji Hospital, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
| | - Sanlan Wu
- Department of Pharmacy, Union Hospital, Tongji Medical College; Huazhong University of Science and Technology; Wuhan People' Republic of China
| |
Collapse
|